S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
OTCMKTS:FSNUY

Fresenius SE & Co. KGaA News Headlines

$11.84
-0.01 (-0.08 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.70
$11.99
50-Day Range
$11.41
$13.91
52-Week Range
$9.17
$14.81
Volume38,924 shs
Average Volume25,657 shs
Market Capitalization$26.35 billion
P/E Ratio12.73
Dividend Yield1.52%
Beta1.36

Media Mentions By Week

Fresenius SE & Co. KGaA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FSNUY
News Sentiment

0.66

0.36

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FSNUY Articles
This Week

3

0

FSNUY Articles
Average Week

Get Fresenius SE & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

Fresenius SE & Co. KGaA (OTCMKTS FSNUY) News Headlines Today

SourceHeadline
MarketBeat logoHead to Head Contrast: Bioventus (NYSE:BVS) & Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)
americanbankingnews.com - October 13 at 11:11 PM
MarketBeat logoFresenius SE & Co. KGaA (OTCMKTS:FSNUY) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - October 2 at 6:48 AM
MarketBeat logoShort Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Declines By 61.9%
americanbankingnews.com - October 1 at 2:58 AM
msn.com logoOminous Death Cross Forms On Fresenius Medical Care's Chart
msn.com - September 22 at 2:19 PM
marketwatch.com logoParenteral Nutrition Market to Eyewitness Huge Growth by 2027 | Grifols, Pfizer, Baxter International, Fresenius
marketwatch.com - June 28 at 5:31 AM
marketwatch.com logoDisposable Blood Transfusion Bag Market 2021 Global Industry Analysis by Trends, Size, Share, Company Overview and Growth Forecast to 2026
marketwatch.com - June 1 at 2:19 PM
nasdaq.com logoFresenius Q1 Net Income Before Special Items Declines; Confirms FY21 Guidance
nasdaq.com - May 6 at 2:30 AM
marketwatch.com logoTotal Fluid Management Market Size 2021 Research Report including Industry Segment by Type, Historical Data and Market Forecast to 2026 - MarketWatch
marketwatch.com - April 16 at 2:26 PM
uk.finance.yahoo.com logoCOMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius EUR 3 Tranche
uk.finance.yahoo.com - March 23 at 7:53 AM
finance.yahoo.com logoIs FRESENIUS SE&CO (FSNUY) a Great Value Stock Right Now?
finance.yahoo.com - February 8 at 12:33 PM
finance.yahoo.com logoAre Investors Undervaluing Fresenius (FMS) Right Now?
finance.yahoo.com - December 30 at 12:34 PM
wsj.com logoFresenius SE & Co. KGaA ADR
wsj.com - December 26 at 11:50 PM
finance.yahoo.com logoCORRECTED-NMC Health sells Spain fertility business to Fresenius Helios
finance.yahoo.com - December 21 at 5:53 AM
marketwatch.com logoInhalation Sedatives Global Market Report 2020-30: COVID-19 Growth and Change
marketwatch.com - December 16 at 10:50 PM
marketwatch.com logoBlood Collection Devices Market Size, Share, Global Analysis, Regional Trends and Comprehensive Research Study Till 2027
marketwatch.com - December 11 at 8:40 AM
seekingalpha.com logoFresenius Q3 2020 In-Depth Review
seekingalpha.com - October 29 at 12:53 PM
markets.businessinsider.com logoFresenius Medical Care earnings: here's what Wall Street expects
markets.businessinsider.com - October 29 at 7:25 AM
reuters.com logoGermany's Fresenius net income beats on strong dialysis, drugs units
reuters.com - October 29 at 7:25 AM
in.reuters.com logoGermany's Fresenius Q3 net income beats on strong earnings at dialysis, drugs units
in.reuters.com - October 29 at 2:25 AM
markets.businessinsider.com logoHere's what to expect from Fresenius SE's earnings report
markets.businessinsider.com - October 28 at 11:21 AM
seekingalpha.com logoFresenius Is Too Cheap To Ignore
seekingalpha.com - October 28 at 6:21 AM
seekingalpha.com logoFresenius Medical Care's Unexciting Capital Markets Day
seekingalpha.com - October 16 at 2:37 AM
marketwatch.com logoGlobal Enteral Feeding Devices Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
marketwatch.com - September 25 at 5:58 PM
cnbc.com logoWe've ignored the collateral damage in health care caused by the coronavirus, Fresenius CEO says
cnbc.com - September 23 at 7:55 AM
seekingalpha.com logoEuropean advisory group backs expanded use of Vifor Fresenius' Velphoro
seekingalpha.com - September 18 at 1:51 PM
seekingalpha.com logoFresenius SE & Co. KGaA (FSNUY) Presents At 18th Annual Global Healthcare Virtual Conference - Slideshow
seekingalpha.com - September 15 at 1:10 PM
seekingalpha.com logoNantKwest's NK-92 bioanalytical testing line licensed to Fresenius Kabi SwissBioSim
seekingalpha.com - September 10 at 2:00 PM
nasdaq.com logoAre Investors Undervaluing FRESENIUS SECO (FSNUY) Right Now?
nasdaq.com - August 24 at 5:12 PM
finanznachrichten.de logoDAX-Dividendenaristokrat Fresenius: Trotz Ergebniseinbruch im Q2 gibt's Wachstum am Horizont!
finanznachrichten.de - August 23 at 3:59 PM
finance.yahoo.com logo3 Reasons Why Fresenius (FMS) Is a Great Growth Stock
finance.yahoo.com - August 20 at 2:19 PM
nasdaq.com logoIs FRESENIUS SECO (FSNUY) a Great Value Stock Right Now?
nasdaq.com - August 7 at 1:35 PM
finance.yahoo.com logoLooking for a Growth Stock? 3 Reasons Why Fresenius (FMS) is a Solid Choice
finance.yahoo.com - August 4 at 1:49 PM
uk.finance.yahoo.com logoFresenius Medical Care reports second-quarter beat as pandemic effects ease
uk.finance.yahoo.com - July 31 at 1:26 AM
uk.reuters.com logoFresenius cuts 2020 goals as pandemic hits services, drugs units
uk.reuters.com - July 30 at 10:25 AM
www.nasdaq.com logoFresenius Q2 EBIT Before Special Items Flat With Prior Year; Organic Sales Growth At 2%
www.nasdaq.com - July 30 at 10:25 AM
www.reuters.com logoUPDATE 2-Fresenius cuts 2020 outlook to reflect pandemic impact
www.reuters.com - July 30 at 10:25 AM
www.msn.com logoFresenius trims guidance after profit falls
www.msn.com - July 30 at 10:25 AM
www.businesswire.com logoHemodialysis Equipment Market Analysis Highlights the Impact of COVID-19 2020-2024 | Shortage in Availability of Kidneys for Transplant to Augment Growth | Technavio
www.businesswire.com - July 1 at 10:32 PM
seekingalpha.com logoFresenius Medical Care: A Solid 2020 Will See Share Price Recapture 2018 Highs
seekingalpha.com - July 1 at 5:32 PM
finance.yahoo.com logoFresenius Kabi Expands MicroVault® Packaging to include Simplist® Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes
finance.yahoo.com - June 24 at 5:27 PM
www.benzinga.com logoGlobal Elastomeric Infusion Pumps Market to Surge at 7.50% CAGR, Coronavirus Outbreak Might Impact Growth, Says Market.us
www.benzinga.com - June 24 at 7:26 AM
www.businesswire.com logoAssessment of COVID-19's Effect on Heparin Market 2020-2024 | Increasing Prevalence of Chronic Conditions to Augment Growth | Technavio
www.businesswire.com - June 23 at 3:40 PM
www.businesswire.com logoAssessment of COVID-19's Effect on Enteral Feeding Devices Market 2020-2024 | Growing Number of Strategic Alliances to Augment Growth | Technavio
www.businesswire.com - June 19 at 3:16 PM
www.businesswire.com logoBurden of COVID-19 on the Market & Rehabilitation Plan | Clinical Nutrition Market 2020-2024 | Rising Geriatric Population to Boost Growth | Technavio
www.businesswire.com - June 15 at 10:33 PM
finance.yahoo.com logoSedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients
finance.yahoo.com - June 15 at 10:33 PM
www.msn.com logoSimon Counts on Seasoned Lawyer to Snuff Out Taubman Mall Buyout
www.msn.com - June 10 at 7:36 PM
seekingalpha.com logoFresenius Medical Care (FMS) Presents At UBS Virtual Best Of Europe Conference - Slideshow
seekingalpha.com - May 29 at 5:34 PM
www.marketwatch.com logoFresenius buys hospital in Germany
www.marketwatch.com - May 29 at 7:34 AM
www.marketwatch.com logoFresenius Kabi, Medac agree marketing deal
www.marketwatch.com - May 28 at 9:54 AM
www.businesswire.com logoFDA Accepts for Review Fresenius Kabi’s BLA Submission for Pegfilgrastim Biosimilar
www.businesswire.com - May 27 at 1:10 PM
Get Fresenius SE & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.